phosphorylethanolamine has been researched along with Cancer of Mouth in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, C | 1 |
| Ho, A | 1 |
| Nusbaum, A | 1 |
| Xu, R | 1 |
| Davey, ME | 1 |
| Nichols, F | 1 |
| Mao, C | 1 |
| Movila, A | 1 |
1 other study available for phosphorylethanolamine and Cancer of Mouth
| Article | Year |
|---|---|
Inhibitory effect of Porphyromonas gingivalis-derived phosphoethanolamine dihydroceramide on acid ceramidase expression in oral squamous cells.
Topics: Acid Ceramidase; Carcinoma, Squamous Cell; Ceramides; Epithelial Cells; Head and Neck Neoplasms; Hum | 2023 |